Dietary Supplement Climea Forte 30tabs.

£9.9
FREE Shipping

Dietary Supplement Climea Forte 30tabs.

Dietary Supplement Climea Forte 30tabs.

RRP: £99
Price: £9.9
£9.9 FREE Shipping

In stock

We accept the following payment methods

Description

In women with pre-existing hypertriglyceridemia, estrogen therapy may be associated with elevations of plasma triglycerides leading to pancreatitis. Consider discontinuation of treatment if pancreatitis occurs. Hepatic Impairment And/Or Past History Of Cholestatic Jaundice Risk factors for arterial vascular disease (for example, hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, and obesity) and/or venous thromboembolism (VTE) (for example, personal history or family history of VTE, obesity, and systemic lupus erythematosus) should be managed appropriately. Stroke

isoflavones from soya - 60 mg Calcium - 400 mg, vitamin D3 - 5 mg, vitamin B6- 1.4 mg Vitamin E 12 mg equivalent of alpha-tocopherol, folic acid - 200 mg Other ingredients: Calcium carbonate cellulose (bulking), soy isoflavones, hydroxypropyl methylcellulose (glazing agent), extract of hops, succinate, D-alpha-tocopheryl acetate, magnesium salts of fatty acids (glazing agent), flaxseed ground, sodium carboxymethylcellulose, cross-linked (bulking agent), carbon titanium (dye), hydroxypropyl cellulose (glazing agent), cholecalciferol, pyridoxine hydrochloride, folic acid, quinoline yellow (color), sunset yellow FCF (dye), beeswax and carnauba wax (glazing agents) .This material includes yellow quinoline yellow and orange. The product contains soy and derivatives. In the WHI estrogen plus progestin substudy, a statistically significant 2-fold greater rate of VTE was reported in women receiving daily CE (0.625 mg) plus MPA (2.5 mg) compared to women receiving placebo (35 versus 17 per 10,000 women-years). Statistically significant increases in risk for both DVT (26 versus 13 per 10,000 women-years) and PE (18 versus 8 per 10,000 women-years) were also demonstrated. The increase in VTE risk was demonstrated during the first year and persisted 4. Should a VTE occur or be suspected, estrogen plus progestin therapy should be discontinued immediately. There is no evidence that the use of natural estrogens results in a different endometrial risk profile than synthetic estrogens of equivalent estrogen dose. Adding a progestin to estrogen therapy in postmenopausal women has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer. Breast Cancer

Food Interaction

receiving reports on adverse effects (the legal basis for processing is a legal obligation to which Aflofarm is subject – Article 6(1)(c) of the GDPR); Depression, migraine, paresthesia, dizziness, anxiety, irritability, mood swings, nervousness, insomnia, headache Miscellaneous Other binding proteins may be elevated in serum, for example, corticosteroid binding globulin (CBG), sex hormone-binding globulin (SHBG), leading to increased total circulating corticosteroids and sex steroids, respectively. Free hormone concentrations, such as testosterone and estradiol, may be decreased. Other plasma proteins may be increased (angiotensinogen/renin substrate, alpha-l-antitrypsin, ceruloplasmin). Start therapy with 0.025 mg per day applied to the skin once weekly. Therapy should be started at the lowest effective dose and the shortest duration consistent with the treatment goals. Attempts to taper or discontinue the medication should be made at 3 to 6 month intervals. Treatment Of Moderate To Severe Symptoms Of Vulvar And Vaginal Atrophy Due To Menopause Subgroup analyses of women 50 to 59 years of age suggest no increased risk of stroke for those women receiving CE (0.625 mg)-alone versus those receiving placebo (18 versus 21 per 10,000 women-years). 1

Clinically significant blood pressure increases have been reported during estrogen therapy, particularly in patients receiving high dosages or treated with oral contraceptive combinations having high progestational activity. Climea Forte helps in relieving the symptoms of menopause, including hot flushes, sweating, anxiety, irritability (hops extract). Supports weight control and helps maintain digestive comfort (flax). Supports the maintenance of healthy bones (calcium and vitamin D), contributes to the reduction of tiredness and fatigue (vitamin B6, folates). Also helps to protect cells against oxidative stress (vitamin E) and supports the proper functioning of the nervous system (vitamin B6). Increased plasma high-density lipoprotein (HDL) and HDL 2 cholesterol subfraction concentrations, reduced low-density lipoprotein (LDL) cholesterol concentration, and increased triglyceride levels. The following adverse reactions have been identified during post-approval use of the Climara Forte transdermal system. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Genitourinary SystemThe use of estrogen-alone and estrogen plus progestin has been reported to result in an increase in abnormal mammograms requiring further evaluation.

c) Adverse reactions occurring in placebo group in Climara Forte trial of clinical efficacy versus placebohttps://www.termedia.pl/Wplyw-zmian-hormonalnych-zachodzacych-w-organizmie-kobiety-na-stan-skory,56,12608,0,0.html In the WHI estrogen-alone substudy, the risk of VTE (DVT and PE) was increased for women receiving daily CE (0.625 mg)-alone compared to placebo (30 versus 22 per 10,000 women-years), although only the increased risk of DVT reached statistical significance (23 versus 15 per 10,000 women-years). The increase in VTE risk was demonstrated during the first 2 years 3. Should a VTE occur or be suspected, estrogen-alone therapy should be discontinued immediately. The adhesion assessment was done visually on Days 2, 4, 5, 6, 7 of each week of transdermal system wear. A total of 1,654 adhesion observations were conducted for 333 transdermal systems of each size. handling complaints – legitimate interest of the Controller – Article 6(1)(f) of the GDPR. The basis for personal data processing will be Article 6(1)(b) of the GDPR, where necessary to perform a contract to which you are a party or to take steps at your request prior to entering into a contract. Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer. A woman without a uterus does not need a progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin.



  • Fruugo ID: 258392218-563234582
  • EAN: 764486781913
  • Sold by: Fruugo

Delivery & Returns

Fruugo

Address: UK
All products: Visit Fruugo Shop